A newly published study explored patient-reported performance measures in oncology, the barriers to implementation, and actionable recommendations for public and private payers to improve the appropriate use of these measures in oncology value-based payment programs.
Key findings include:
- Within a universe of over 800 available PR-PMs, 515 crosscutting measures are applicable to oncology; and only 18 oncology-specific PR-PMs were identified. Some of this small number are already used in VBP programs.
- Gaps in available oncology PRMs and PR-PMs include (but are not limited to) goal attainment, personalized medicine, socioeconomic status and survivorship.
Find out more here.
(Source: NPC; E.V.I.dently Blog; 10/28/20)